Ratings AECI Ltd OTC Markets

Equities

AECLY

US0010122028

Market Closed - OTC Markets Other stock markets 08:10:00 2023-11-28 pm EST			5-day change	1st Jan Change
7.9 ^USD	-.--%		-.--%	-.--%

Feb. 28	Transcript : AECI Ltd, 2023 Earnings Call, Feb 28, 2024
Feb. 27	AECI Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

Its low valuation, with P/E ratio at 6.65 and 5.2 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
The stock, which is currently worth 2024 to 0.22 times its sales, is clearly overvalued in comparison with peers.
The company's share price in relation to its net book value makes it look relatively cheap.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
The company is one of the best yield companies with high dividend expectations.
Over the last twelve months, the sales forecast has been frequently revised upwards.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
AECI LTD	-.--%	558M	-
ECOLAB INC.	+17.80%	66.73B	A-
SIKA AG	+2.92%	49.79B	A-
GIVAUDAN SA	+19.98%	42.5B	B+
FUJIFILM HOLDINGS CORPORATION	+20.88%	26.45B	A-
EMS-CHEMIE HOLDING AG	+12.04%	19.66B	C+
CELANESE CORPORATION	+1.27%	17.18B	B+
POSCO FUTURE M CO., LTD.	-22.98%	15.82B	A-
SYMRISE AG	+2.77%	15.56B	B+
ALBEMARLE CORPORATION	-9.25%	15.41B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes